Navigation Links
Intercell and Romark Join Forces in Combining Therapies Against Hepatitis C
Date:10/21/2010

ng statements concerning Intercell AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of Intercell AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Intercell AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.____________________________(1) Rossignol JF. Thiazolides: A new class of antiviral drugs. Expert Opin Drug Metab Toxicol. 2009;5:667-674.(2) Korba BE, Montero AB, Farrar K, et al. Nitazoxanide, tizoxanide, and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication. Antivir Res. 2008;77:56-63.(3) Korba BE, Elazar M, Lui P, et al. Studies of the potential for hepatitis C virus resistance to nitazoxanide or tizoxanide. Antimicrob Agents Chemother. 2008;52:4069-4071.(4) Yon C, Viswanathan P, Rossignol JF, Korba BE. Resistance to nitazoxanide is associated with alterations in the host and not the virus in HCV replicon-containing cultures. Submitted for publication.(5) Korba BE, Elazar M, Liu P, et al. Potential role for nitazoxanide in combination with STAT-C agents for the inhibition of HCV replication without the development of resistance. Hepatology. 2008;48(suppl):356A.(6) Rossignol JF, Kabil SM, El-Gohary Y, Elfert A, Keeffe EB. Clinical trial: randomized, double-blind, placebo-controlled study of nitazoxanide monotherapy for the treatment of patients with chronic hepatitis C genotype 4. Aliment Pharmacol Ther. 2008;28:574-580.(7) Rossignol JF, Elfert A, El-Gohary Y, et al. Improved virologic response in patients with chronic hepatitis C genotype 4 treated with nitazoxanide plus peginterferon alfa-2a with or with
'/>"/>
SOURCE Intercell AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Intercell AG Appoints Staph Leavenworth Bakali as Chief Business Officer
2. Intercell Acquires Antibody Technology Platform to Further Exploit Its Capabilities to Combat Infectious Diseases
3. Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS
4. Intercell Starts a Phase I Clinical Trial for a New Streptococcus pneumoniae Vaccine
5. Intercell AG Partners with Inclinix to Enroll 1800 Volunteers for Phase III Travelers Diarrhea Vaccine Study
6. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
7. Favourable Six Months Follow-Up Results From Intercells Phase II Therapeutic Hepatitis C Program
8. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
9. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
10. NeuroFocus and New Scientist Magazine Apply Neuromarketing to Select Cover Design
11. Romark Initiates Clinical Trial of Alinia for Treatment of Influenza
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , November 26, 2014 Investor-Edge ... VVUS ), Horizon Pharma PLC (NASDAQ: ... and Johnson (NYSE: JNJ ), and Theravance Inc. ... companies can be accessed at: http://investor-edge.com/register . ... 4,758.25, up 0.07%, the Dow Jones Industrial Average edged 0.02% ...
(Date:11/26/2014)... , Inc. (NASDAQ: BIOS ) announced today that ... at the Bank of America Merrill Lynch 2014 Leveraged Finance Conference ... , Wednesday, December 3, 2014 , , , , Time: ... Location: , , , Boca Raton Resort and Club, Florida , ... BioScrip, Inc. is a leading national provider of infusion and ...
(Date:11/26/2014)... , Nov. 26, 2014 Zynerba Pharmaceuticals ... development of innovative transdermal synthetic cannabinoid treatments, today announced ... 26th Annual Healthcare Conference 2014. The conference will be ... Palace in New York . Zynerba,s ... at 4:50 pm on Tuesday, December 2. ...
Breaking Medicine Technology:Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5Zynerba Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2014 2
... UCB and Harvard University officially launched their innovative Research ... Boston last night in the presence of his Royal ... http://photos.prnewswire.com/prnh/20110630/NY28450 ) The Alliance creates a ... Harvard scientists continuing their research that holds potential for ...
... announces that a new market research report is ... Devices & Diagnostics Equipments in India ... the Indian Medical Devices & equipments market is ... annually. India is growing as a ...
Cached Medicine Technology:UCB Launches Research Alliance with Harvard University 2UCB Launches Research Alliance with Harvard University 3Medical Devices & Diagnostics Equipments in India 2Medical Devices & Diagnostics Equipments in India 3Medical Devices & Diagnostics Equipments in India 4Medical Devices & Diagnostics Equipments in India 5
(Date:11/28/2014)... November 28, 2014 Nipomo Family ... Christina Do, recently opened its doors at 195 N. ... Along with preventative care like teeth cleanings, oral exams, ... dentistry, Invisalign, teeth whitening (and Kor whitening), laser whitening, ... addition, Nipomo Family Dentistry’s five-person team also takes a ...
(Date:11/27/2014)... One of the major segments of ... implant dentistry comprises dental implants and abutments as ... dental care is bifurcated into two segments: dental ... is composed of large equipment. , View full ... , The worldwide dental market is growing ...
(Date:11/27/2014)... The report “Blepharitis – Pipeline ... therapeutic development for Blepharitis, complete with comparative analysis ... mechanism of action (MoA), route of administration (RoA) ... featured news and press releases. It also reviews ... Blepharitis and special features on late-stage and discontinued ...
(Date:11/27/2014)... Petersburg, Fl (PRWEB) November 28, 2014 Let ... , Beautiful Christmas boxes with bows on top, filled with ... All prices are deeply discounted today while quantities last - ... . , All products are also available on Amazon at ... found on each Sublime shop product page for ease. , ...
(Date:11/27/2014)... 27, 2014 In a world ... to sleep has lessened, and due to the ... quality of sleep has eroded. According to Web ... the job (Reference: http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). This remarkably ... by an incalculable amount, leading not only to ...
Breaking Medicine News(10 mins):Health News:Nipomo Family Dentistry Opens New Dental Office in Nipomo 2Health News:Nipomo Family Dentistry Opens New Dental Office in Nipomo 3Health News:Dental Market Research Report 2014 - Global Industry Size, Share, Trends, Growth, Retail Sales Value and Forecast by Researchmoz.us 2Health News:Dental Market Research Report 2014 - Global Industry Size, Share, Trends, Growth, Retail Sales Value and Forecast by Researchmoz.us 3Health News:Blepharitis Pipeline Market Review on Drugs and Companies H2 2014 2Health News:Blepharitis Pipeline Market Review on Drugs and Companies H2 2014 3Health News:Blepharitis Pipeline Market Review on Drugs and Companies H2 2014 4Health News:Big Christmas Sales Begin Today at Sublime Beauty® for all Christmas Gift Selections and Skincare Sets 2Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2
... , SATURDAY, May 21 (HealthDay News) -- As summer ... heat-related illnesses, experts say. "We are not invincible ... Brendon McDermott, an athletic trainer with the University of ... Institute (KSI) Medical and Science Advisory Board, in a ...
... (May 20, 2011)The American Federation for Aging Research (AFAR) today ... fellows and junior faculty at 27 Centers of Excellence in ... funded with support from the John A. Hartford Foundation, has ... cadre of academic leaders in geriatrics. As our nation ages, ...
... discs in the low back wear out, become compressed and ... discs can be a viable alternative to standard fusion surgery, ... recently published in the Journal of Bone and Joint ... fusion but this is believed the first to evaluate the ...
... are treated for cancer during childhood have a significantly higher ... severe later in life, according to a study led ... the need for childhood cancer survivors and their physicians to ... health care needs are met. "We have, in a ...
... , FRIDAY, May 20 (HealthDay News) -- The number of ... in recent years, a new government study shows. Researchers ... data from birth certificates for more than 4 million live ... previous years. The investigators found that 28,357 babies were ...
... of UT Dallas is known throughout the world for his ... at The University of Texas at Dallas, he,s known to ... received the President,s Teaching Excellence Award for Tenure-Track Faculty during ... from among more than 100 eligible faculty members who were ...
Cached Medicine News:Health News:Keeping Cool in the Heat 2Health News:AFAR announces the 2011 Hartford Scholars in Geriatric Medicine 2Health News:2-year results: Artificial disc a viable alternative to fusion for 2-level disc disease 2Health News:Childhood cancer survivors at higher risk for future GI complications 2Health News:Home Births Jump 20 Percent in 4 Years: U.S. Report 2Health News:Home Births Jump 20 Percent in 4 Years: U.S. Report 3Health News:UT Dallas' Moller receives teaching award 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: